Sunday, September 27, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· February 9, 2026

dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners

View original at globenewswire.com
dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners Press Release dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners Kaiseraugst (Switzerland), Maastricht (Netherlands), February 9, 2026 dsm-firmenich, innovators in nutrition, health,…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • This agreement opens an exciting new chapter for ANH, enabling it to thrive and realize its full potential

    80% confidence
  • dsm-firmenich expects to receive approximately €1.2 billion after closing of which an estimated €0.6 billion in net cash proceeds, an estimated €0.5 billion in debt and liability transfers to the ANH Companies, and €0.1 billion in the form of a vendor loan note

    80% confidence
  • dsm-firmenich expects to incur cash tax, transaction and separation costs of €0.2 billion in 2026

    80% confidence
  • The Solutions Company will continue to drive innovation and efficiency in animal farming, delivering tailored solutions with high proximity to its global customer base

    80% confidence
  • The Essential Products Company will be built as a resilient global leader in essential feed, food and fragrance ingredients, providing customers with reliable, high-quality supply based on an independent and highly integrated value chain

    80% confidence
  • Since the creation of dsm-firmenich, we have consistently delivered on every milestone in our strategic roadmap. This transaction marks the final step in that journey and reflects our commitment to accelerating our growth and creating long-term value for all stakeholders.

    80% confidence
  • The transaction is expected to be completed at the end of 2026 and is subject to conditions including regulatory approvals, finalization of employee consultation processes and creation and separation of standalone companies

    80% confidence
  • This transaction represents a unique opportunity to create two new leading companies in the animal nutrition & health space with significant potential for value creation

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Vertical AI Agents Attract a Funding Wave Across Fintech-Adjacent Industries
A cluster of AI-native startups applying autonomous agents to narrow, operational problems — hotel front-desk staffing (Dextr AI), identity/fraud risk for financial institutions (Baselayer), insurance distribution (Napo, Connie Health, MGT Insurance) — closed seed-to-Series A rounds within days of each other in September 2026, with CB Insights running a coordinated CEO interview series to spotlight them. The pattern points to agentic AI maturing from generic chat tools into vertical, revenue-generating products, with identity verification for AI agents themselves (Baselayer) emerging as a new fintech infrastructure category responding directly to AI-driven fraud risk.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,984
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,984 facts checked against source5,306 source documents archived
Query this data → isubstrate.com
dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners — Source | Via News | Via News